Volume 77, Issue 4 pp. 535-538
Full Access

Variable inactivation of human factor VIII from different sources by human factor VIII inhibitors

Janet D. Littlewood

Corresponding Author

Janet D. Littlewood

University of Cambridge, Department of Clinical Veterinary Medicine, Madingley Road, Cambridge

Animal Health Trust, Newmarket, Sufolk

Dr Janet D. Littlewood, Animal Health Trust, P.O. Box 5, Newmarket, Suffolk CB8 7DW.Search for more papers by this author
Sally A. Bevan

Sally A. Bevan

Animal Health Trust, Newmarket, Sufolk

Search for more papers by this author
Geoffrey Kemball-Cook

Geoffrey Kemball-Cook

National Institute of Biological Standards and Control South Mymms, Potters Bar, Herts.

Search for more papers by this author
Richard J. Evans

Richard J. Evans

University of Cambridge, Department of Clinical Veterinary Medicine, Madingley Road, Cambridge

Search for more papers by this author
Trevor W. Barrowcliffe

Trevor W. Barrowcliffe

National Institute of Biological Standards and Control South Mymms, Potters Bar, Herts.

Search for more papers by this author
First published: April 1991
Citations: 12

Abstract

Summary. The source of human factor VIIII (FVIII) had a marked effect on the inhibitory activity of a panel of eight human FVIII inhibitors. Use of conventional FVIII concentrates gave lower inhibitor titres whereas a monoclonal antibody purified FVIII concentrate gave titres similar to or greater than those with plasma. Addition of phospholipid (PL) protected highly purified FVIII against inhibition. The content of PL-bound FVIII in concentrates may account for the observed differences.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.